Pfizer's Strategic Turnaround in the Post-Pandemic Era
Pfizer is making significant strides in its recovery post-pandemic, showcasing strategic initiatives that are positively impacting investor sentiment.
Editorial Staff 3 days ago
2 articles tagged with "Pfizer"
Pfizer is making significant strides in its recovery post-pandemic, showcasing strategic initiatives that are positively impacting investor sentiment.
Replimune is set to make a third attempt for FDA approval of its drug, while Pfizer has recently secured a deal in China, highlighting ongoing developments in the pharmaceutical sector.